J
Jingnan Wang
Researcher at Peking Union Medical College
Publications - 7
Citations - 96
Jingnan Wang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 61 citations.
Papers
More filters
Journal ArticleDOI
First-in-human study of 177 Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Jie Zang,Xingrong Fan,Hao Wang,Qingxing Liu,Jingnan Wang,Hui Li,Fang Li,Orit Jacobson,Gang Niu,Zhaohui Zhu,Zhaohui Zhu,Xiaoyuan Chen +11 more
TL;DR: This first-in-human study demonstrated that 177Lu-EB-PSMA-617 had higher accumulation in mCRPC and that low imaging dose appears to be effective in treating tumors with high 68Ga-PSma-617 uptakes.
Journal ArticleDOI
Response to Single Low-dose 177Lu-DOTA-EB-TATE Treatment in Patients with Advanced Neuroendocrine Neoplasm: A Prospective Pilot Study.
Hao Wang,Yuejuan Cheng,Jingjing Zhang,Jie Zang,Hui Li,Qingxing Liu,Jingnan Wang,Orit Jacobson,Fang Li,Fang Li,Zhaohui Zhu,Zhaohui Zhu,Xiaoyuan Chen +12 more
TL;DR: A single low-dose 177Lu-DOTA-EB-TATE treatment appears to be safe and effective in the treatment of NENs with high 68Ga-Dota-Tate uptake.
Journal ArticleDOI
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies
TL;DR: In this article , the authors performed a pilot visualization study to investigate in vivo fibroblast activation in non-ischemic cardiomyopathies by 68 Ga-FAPI-04 PET/CT.
Journal ArticleDOI
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
Xuezhu Wang,Xu Yang,Jingnan Wang,Chen-Yuan Dong,Jie Ding,Mei-Han Wu,Yanyu Wang,Haiyan Ding,Hui Zhang,Xinting Sang,Haitao Zhao,Li Huo +11 more
TL;DR: In this article , the authors investigated the prognostic value of metabolic parameters from 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) in patients with uHCC who underwent the combined therapies.
Journal ArticleDOI
In Vivo Fibroblast Activation of Systemic Sarcoidosis: A 68Ga-FAPI-04 PET/CT Imaging Study
TL;DR: In this article , a 47-year-old female with cardiac dysfunction and lymphadenopathy underwent 18FDG PET/CT and 68Ga-FAPI-04 imaging for tumor screening.